Hepatocellular adenoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{ZAS}} | {{CMG}}; {{AE}}{{ZAS}} | ||
==Overview== | ==Overview== | ||
An | An annual follow-up with [[Magnetic resonance imaging|MRI]] or [[ultrasound]] may be scheduled for female patients until [[menopause]]. | ||
== | ==Secondary Prevention== | ||
An annual follow-up with [[Magnetic resonance imaging|MRI]] or [[ultrasound]] may be scheduled for female patients until [[menopause]], when:<ref>{{Cite journal | |||
| author = [[Maarten G. Thomeer]], [[Mirelle Broker]], [[Joanne Verheij]], [[Michael Doukas]], [[Turkan Terkivatan]], [[Diederick Bijdevaate]], [[Robert A. De Man]], [[Adriaan Moelker]] & [[Jan N. IJzermans]] | | author = [[Maarten G. Thomeer]], [[Mirelle Broker]], [[Joanne Verheij]], [[Michael Doukas]], [[Turkan Terkivatan]], [[Diederick Bijdevaate]], [[Robert A. De Man]], [[Adriaan Moelker]] & [[Jan N. IJzermans]] | ||
| title = Hepatocellular adenoma: when and how to treat? Update of current evidence | | title = Hepatocellular adenoma: when and how to treat? Update of current evidence | ||
| Line 18: | Line 18: | ||
| pmid = 27803743 | | pmid = 27803743 | ||
}}</ref> | }}</ref> | ||
* The [[adenoma]] is < 5 cm in diameter | |||
* It has [[Regression|regressed]] to < 5 cm after discontinuation of [[Oral contraceptive|oral contraceptive medications]] | |||
==References== | ==References== | ||
Latest revision as of 13:10, 23 August 2019
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma secondary prevention |
|
Risk calculators and risk factors for Hepatocellular adenoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]
Overview
An annual follow-up with MRI or ultrasound may be scheduled for female patients until menopause.
Secondary Prevention
An annual follow-up with MRI or ultrasound may be scheduled for female patients until menopause, when:[1]
- The adenoma is < 5 cm in diameter
- It has regressed to < 5 cm after discontinuation of oral contraceptive medications
References
- ↑ Maarten G. Thomeer, Mirelle Broker, Joanne Verheij, Michael Doukas, Turkan Terkivatan, Diederick Bijdevaate, Robert A. De Man, Adriaan Moelker & Jan N. IJzermans (2016). "Hepatocellular adenoma: when and how to treat? Update of current evidence". Therapeutic advances in gastroenterology. 9 (6): 898–912. doi:10.1177/1756283X16663882. PMID 27803743. Unknown parameter
|month=ignored (help)